Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial. (2019)

First Author: Gold J
Attributed to:  A Programme for ALS Care in Europe (ALS-CarE) funded by ESRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/21678421.2019.1632899

PubMed Identifier: 31284774

Publication URI: http://europepmc.org/abstract/MED/31284774

Type: Journal Article/Review

Volume: 20

Parent Publication: Amyotrophic lateral sclerosis & frontotemporal degeneration

Issue: 7-8

ISSN: 2167-8421